Objective: To assess the efficacy, safety and tolerability of moxifloxacin, an 8-methoxy fluoroquinolone, in patients with respiratory tract infections (RTIs) treated in general practice in Germany.

Objective: To assess the efficacy, safety and tolerability of oral moxifloxacin in outpatients with respiratory tract infections treated in general practices in Germany with the focus on community ...

Paratek will accelerate access for XHANCE beyond specialists to primary care providers maximizing the recent label expansion for CRS in a ...

In adults and adolescents aged 14 years and older with rifampin-resistant, fluoroquinolone-susceptible pulmonary TB, the panel recommended a 6-month regimen consisting of bedaquiline, pretomanid, ...

Many medicines taste so bitter that some people avoid taking them. To help with the bad taste, flavors and sweeteners are ...

For fluoroquinolones, norfloxacin is metabolised mostly, accounting for 30% of total administered dose. Moxifloxacin is metabolised via a type 2 reaction in bile. Ciprofloxacin is partially ...

Scientists examined the bitterness intensity of five medicines and two bitter modifiers in 338 adults of European descent and recent US and Canadian immigrants from Asia, South Asia, and Africa.

In this population, oral tetracycline, oral minocycline, oral moxifloxacin, oral clindamycin, and oral dapsone may be used, as well as intravenous ertapenem for severe, recalcitrant cases. For those ...

The NHS has issued a warning about the potential hazards of ibuprofen, advising those with certain symptoms such as a runny ...

A prospective cohort study of patients with drug-resistant tuberculosis (TB) in Belarus and Uzbekistan found that the 6-month, all-oral treatment regimens recommended by the World Health Organization ...